Publications, Pharmaceutical

Delivering On The Promises of Intranasal Vaccination

Intranasal vaccination offers a number of valuable benefits. Nasal vaccines are easy to self-administer, non-invasive and trigger a broad immune response, notably mucosal immunity. This article reviews the advantages of intranasal vaccination, the challenges associated with developing nasal spray vaccines and recent advances in the field. COVID-19 has had a hugely disruptive impact on the vaccines market. Although only four nasal spray vaccines are currently in commercial use a significant number of intranasal spray vaccines for COVID-19 are in development, holding out the promise of adding mucosal immunity to improve resistance to the virus. Device design and emerging strategies for successful vaccine formulation are discussed.

Download Publication
Author(s): Dr. Julie Suman Nektaria Karavas
18 Nov 2021

This Might Also Be of Interest

8 Sep 2022

Case Study – Bidose Nasal Spray Pump for Depression

Case Studies, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
8 Sep 2022

Case Study – Unidose Nasal Spray Pump in Hypoglycemia

Case Studies, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
8 Sep 2022

Case Study – Unidose Nasal Spray Pump for Opioid Overdose

Case Studies, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
1 Sep 2022

Spray Dried Formulations for Nasal Applications – Challenges an...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
1 2 3 16
Back To Top